Improvement in binge eating in non-diabetic obese individuals after 3 months of treatment with liraglutide - A pilot study
{{output}}
We examined the effects of liraglutide, a glucagon-like peptide-1 analogue on appetite and plasma ghrelin in non-diabetic obese participants with subclinical binge eating (BE). Forty-four obese BE participants (mean age: 34±9 years, BMI: 35.9±4.2kg/m(2)) wer... ...
